# Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity

> **NCT06132984** · — · RECRUITING · sponsor: **West China Second University Hospital** · enrollment: 22 (estimated)

## Conditions studied

- Immune Checkpoint Inhibitors, Cardiotoxicity

## Interventions

- **DIAGNOSTIC_TEST:** Cardiac magnetic resonance

## Key facts

- **NCT ID:** NCT06132984
- **Lead sponsor:** West China Second University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-23
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06132984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06132984, "Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06132984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*